Proton pump inhibitors (PPI) vs H2RA, placebo or no treatment: Surgery ‐ within 30 days
Proton pump inhibitor treatment showed no clear difference in surgery ‐ within 30 days compared with H2RA, placebo or no treatment (low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Proton pump inhibitor treatment vs H2RA, placebo or no treatment Surgery ‐ within 30 days · people with upper gastrointestinal bleeding prior to endoscopic diagnosis Proton pump inhibitor treatment showed no clear difference in surgery ‐ within 30 days compared with H2RA, placebo or no treatment (low certainty). Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding (2022) · Cochrane Headline outcomes only | OR 0.91 [0.65, 1.26] | 6 studies · 2223 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding 2022 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.